Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis Biotech Investing
TRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium Therapeutics Inc. - TRIL Biotech Investing
Trillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - TRIL Biotech Investing
BriaCell to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 Biotech Investing
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021 Biotech Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Orencia for the Prevention of Acute Graft Versus Host Disease Biotech Investing
U.S. Food and Drug Administration Approves Opdivo® for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma Biotech Investing
European Medicines Agency Validates Gilead's Marketing Authorization Application for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Abecma , the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma Biotech Investing
